Watch any testosterone therapy commercial and you are left with the impression that the men taking the supplements have the most satisfying lives imaginable. Salt and peppered hair, perfectly shaped of course, sits atop the head of a man who has taken the world by storm. His convertible sports car takes him to work and to the country club. He plays tennis and golf. And, he comes home to a beautiful lover every night.
As he walks into his oversized house ...
continue reading...
Testosterone lawsuits filed as part of the multidistrict litigation (MDL) in the U.S. District Court for the Northern District of Illinois are now in excess of 2,000, according to the MDL web page. The number is up from 1,500 two months ago. The testosterone MDL was established in June 2014, and initially included eight separate testosterone lawsuits. Plaintiffs who have filed lawsuits in the MDL ...
Pharmaceutical giant AbbVie, Inc. has reported a 4.3 percent increase in its first-quarter profits, according to Nasdaq. The Chicago-based company cited heightened sales of anti-inflammatory medications, and detailed its plans to keep its top-selling drug Humira afloat.
Despite the rise in profits, AbbVie still faces financial trouble in the form of testosterone lawsuits. The company’s popular “low-T” product, AndroGel, is one of a handful or prescription testosterone ...
continue reading...A recent Forbes article explores the prevalence of “Low-T” drug ads by companies like AbbVie and Eli Lilly & Co., and how two men’s health experts think the advertisements should be banned.
Testosterone therapy products have been associated with an increased risk of serious cardiovascular health effects. A study published in November 2013 linked testosterone therapy to increased rates of heart attack, stroke, and ...
continue reading...According to the website of the U.S. District Court for the Northern District of Illinois, the multidistrict testosterone therapy litigation MDL 2545 now includes 1,530 testosterone lawsuits—nearly 200 more than it did just one month ago. The multidistrict testosterone litigation was established in June 2014, and initially consisted of eight separate testosterone lawsuits. Testosterone lawsuits claim that testosterone therapy products from companies like AbbVie and Eli Lilly ...
Antares Pharma Incorporated saw dramatic falls in its stock price after hitting a roadblock in clinical trials of its prescription testosterone product. A patient developed an allergic reaction to the drug during the trial, causing the U.S. Food and Drug Administration (FDA) to request additional safety information. A Reuters’ article discusses the setback for the testosterone therapy manufacturer.
Concerns over the safety of prescription testosterone products have ...
continue reading...
